Current Funding Opportunities
COVID-19 Research:
- Development of Treatments for COVID-19 (MTEC)
- CoV Pandemic Response (MCDC; White paper due 31 May 20)
- COVID-19 Special Edition BAA (BARDA)
- Coronavirus Disease 2019 (COVID-19) (NIH)
Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) for Fiscal Year 2020:
Pre-Announcements
- DoD Epilepsy Research Program
- DoD Multiple Sclerosis Research Program
- DoD Hearing Restoration Research Program
- DoD Kidney Cancer Research Program
- DoD Melanoma Research Program
Full Announcements
- Lung Cancer Research Program (LCRP)(Letter of intent due 15 Jul 20)
- Gulf War Illness Research Program (GWIRP)(Pre-proposal due 29 May 20)
- Neurofibromatosis Research Program (NFRP) (Letter of intent due 25 Jun 20)
- Orthotics and Prosthetics Outcomes Research Program (OPORP)(Letter of intent due 15 Jul 20)
- Peer Reviewed Cancer Research Program (PRCRP)
- Idea Award and Impact Award (Pre-proposal due 14 May 20)
- All other award mechanisms (Letter of intent due 30 Jul 20)
- Peer-Reviewed Medical Research Program (PRMRP)(Due date varies for each award mechanism)
- Prostate Cancer Research Program (PCRP)(Letter of intent due 04 Jun 20)
- Spinal Cord Injury Research Program (SCIRP)(Pre-proposal due 21 May 20)
- Tick-Borne Disease Research Program (TBDRP)(Pre-proposal due 27 May 20)
- Amyotrophic Lateral Sclerosis Research Program (ALSRP)Pre-proposal due 15 Apr 20)
- Bone Marrow Failure Research Program (BMFRP)(Pre-proposal due 11 May 20)
- Autism Research Program (ARP)(Pre-proposal due 28 Apr 20)h
- Military Burn Research Program (MBRP)(Pre-proposal due 15 May 20)
- Ovarian Cancer Research Program (OCRP)(Pre-proposal due 30 Apr 20)
- Peer Reviewed Orthopedic Research Program (PRORP)(Pre-proposal due 27 May 20)
MTEC
Pre-Announcements
Full Announcements
- Navy Multi-Topic: Advanced Biomedical Product Development for Naval Operations RPP
- Military Operational Medicine (MOM): Improving Protection through Metrics for Exposure to Blast, and Enhancing Cognitive Health, Performance, and Psychological Health RPP (Proposal due 22 Apr 20)
- Quality Assurance for Bio-Manufactured Regenerative Medicine Products